The Effect of Omeprazole on Acid and Pepsin Secretion in Duodenal Ulcer Patients
J. A. Wilson, E. J. S. Boyd, K. G. Wormsley
Abstract
J. A. Wilson, E. J. S. Boyd, K. G. Wormsley
Abstract
Studies in humans have shown that omeprazole produces a dose dependent and long lasting inhibition of pentagastrin stimulated and overnight acid secretion (1). In studies of patients with duodenal ulcer, where doses of 20, 30, 40 or 60 mg daily were given for 28 days, the compound has been well tolerated (2). It was of interest, therefore, to compare secretory inhibition in duodenal ulcer patients and normal subjects using the same technique.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Studies in humans have shown that omeprazole produces a dose dependent and long lasting inhibition of pentagastrin stimulated and overnight acid secretion (1). In studies of patients with duodenal ulcer, where doses of 20, 30, 40 or 60 mg daily were given for 28 days, the compound has been well tolerated (2). It was of interest, therefore, to compare secretory inhibition in duodenal ulcer patients and normal subjects using the same technique.
Key concepts: Omeprazole, Pepsin, Pentagastrin, Duodenal ulcer, Gastroenterology, Internal medicine, Secretion, Gastric acid